Last Updated: September 23, 2026

Precision Dose Company Profile


✉ Email this page to a colleague

« Back to Dashboard


What is the competitive landscape for PRECISION DOSE

PRECISION DOSE has four approved drugs.



Summary for Precision Dose
US Patents:0
Tradenames:4
Ingredients:4
NDAs:4

Drugs and US Patents for Precision Dose

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Precision Dose RISPERIDONE risperidone SOLUTION;ORAL 076797-001 Jun 28, 2010 DISCN No No ⤷  Start Trial ⤷  Start Trial
Precision Dose THEOPHYLLINE theophylline ELIXIR;ORAL 085863-001 Approved Prior to Jan 1, 1982 DISCN Yes No ⤷  Start Trial ⤷  Start Trial
Precision Dose Inc PHENTOLAMINE MESYLATE phentolamine mesylate INJECTABLE;INJECTION 207686-001 Jul 14, 2017 AP RX No No ⤷  Start Trial ⤷  Start Trial
Precision Dose Inc FOSFOMYCIN TROMETHAMINE fosfomycin tromethamine FOR SOLUTION;ORAL 217187-001 Jun 3, 2025 AA RX No No ⤷  Start Trial ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.